Actuate Therapeutics, Inc. Common stock

ACTUNASDAQ • USD
0.26 USD
↘ 0.02 (7.47%)🟢LIVE (AS OF 01:55 PM EST)
🟢Market: OPEN

ACTU is currently priced at $0.26. Technical and fundamental signals converge bearish — technicals rate "Sell" while fundamentals read "Sell". Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation metrics place ACTU at a fair price relative to peers.

Technical & fundamental data as of Nov 13, 2026.

Open?$0.29
High?$0.31
Low?$0.26
Prev. Close?$0.29
Volume?128.8K
Avg. Volume?464.3K
VWAP?$0.28
Rel. Volume?0.28x
Bid / Ask
Bid?$0.26 × 500
Ask?$0.30 × 100
Spread?$0.04
Midpoint?$0.28
Valuation & Ratios
Market Cap?7.0M
Shares Out?24.0M
Float?8.1M
Float %?33.7%
P/E Ratio?N/A
P/B Ratio?7.04
EPS?-$0.85
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Actuate Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3). It is developing elraglusib (formerly 9-ING-41), a small molecule that is designed to enter cancer cells and block the function of the enzyme GSK-3B, a master regulator of complex biological signaling cascades, including those mediated by oncogenes, that lead to tumor cell survival, growth, migration, and invasion.
Employees
12
Market Cap
6.9M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2024-08-13
Address
1751 RIVER RUN
FORT WORTH, TX 76107
Phone: 847-986-4190
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
65
Short Sent.?
68
Piotroski F-Score?0/9Weak
Altman Z-Score?-56.43Distress
Confidence?41%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?16.05%High
Short Interest?1.3M
Days to Cover?2.1
Free Float8.1M
Avg Daily Volume611.4K
Settlement Date2026-10-30
Financial Health
Current Ratio?1.25Adequate
Quick Ratio?1.25Adequate
Cash Ratio?1.16Strong
Debt/Equity?0.04Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
83/100
P/E?
N/A▾
P/B?
Peers
100
S&P
27
7.04FAIR▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-0.1CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
3
-2,067.8%WEAK▾
ROA?
S&P
3
-393.4%WEAK▾
Cash Flow & Enterprise
FCF?$-19836202
Enterprise Value?$2.6M
Fundamentals ratios updated end of day